Search for: "Grant v. Pfizer Inc." Results 201 - 220 of 349
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
19 Aug 2011, 9:23 am by Stephen Jenei
Teva’s Lawsuit Against Viagra Patent Wilts Pfizer Inc. [read post]
21 Mar 2022, 5:14 am by Matrix Legal Support Service
The Court was asked to consider Whether accounting debits relating to the grant of share options to employees are a deductible expense for corporation tax purposes. [read post]
18 Mar 2010, 2:30 am
Teva Pharmaceuticals USA, Inc. et al. and Gilead Sciences, Inc., et al. v. [read post]
11 Nov 2009, 8:10 am
New London remain vacant, but that Pfizer, Inc. [read post]
5 Dec 2011, 3:30 am
Blue Ridge Paper Prods., Inc., 551 F.3d 405 (6th Cir.2008), and Westerfeld v. [read post]
14 Apr 2024, 9:05 pm by renholding
In Panuwat, the defendant was an employee of Medivation, Inc., a mid-cap oncology firm that was resisting one hostile bidder (Sanofi S.A.) and encouraging another firm (Pfizer) to outbid Sanofi. [read post]
22 Jun 2011, 4:09 am by Marie Louise
A-G’s opinion published – Merck & Co Inc. v Deutsches Patent- und Markenamt (EPLAW) (The SPC Blog) US: Supreme Court to revisit patentable subject matter eligibility of medical diagnostic methods:  Mayo v Prometheus (Patently-O) (Patent Baristas) (PharmaPatents) (IPBiz) (Patent Law Practice Center) US: Intellectual property problems for personalized medicine (BIOtechNow) US: Supreme Court ruling in Stanford v Roche (IPKat) (IPKat) US:… [read post]
22 Jun 2010, 12:41 pm by Erin Miller
Amicus brief of Paralyzed Veterans of America Amicus brief of the United Spinal Association Title: Kentucky Baptist Homes for Children, Inc. v. [read post]
17 Feb 2012, 5:17 am by Nicholas J. Wagoner
Pfizer, Inc., 562 F.3d 163, 174 (2d Cir. 2009); Sarei v. [read post]
27 Jan 2010, 3:00 am
Lupin Ltd. concerning LoSeasonique and Takeda Pharmaceutical Company Limited et al v. [read post]
24 Feb 2010, 2:11 am
(IP Watch) Exploring a new angle in the TRIPS and drug patents debate (Spicy IP) EPO Enlarged Board of Appeal rules on patenting a method of treatment by surgery: G1/07 (IPKat) (EPLAW) (Patent Baristas) EPO Enlarged Board of Appeal decides on dosage regime – Swiss-type claims no longer available: G 2/08 – Dosage Regime/Abbot Respiratory (EPLAW) (Managing Intellectual Property) (IPKat) (Patent Baristas) India: Victory for access to medicines as Bayer loses lawsuit in India (GenericsWeb)… [read post]
24 Feb 2010, 2:11 am
(IP Watch) Exploring a new angle in the TRIPS and drug patents debate (Spicy IP) EPO Enlarged Board of Appeal rules on patenting a method of treatment by surgery: G1/07 (IPKat) (EPLAW) (Patent Baristas) EPO Enlarged Board of Appeal decides on dosage regime – Swiss-type claims no longer available: G 2/08 – Dosage Regime/Abbot Respiratory (EPLAW) (Managing Intellectual Property) (IPKat) (Patent Baristas) India: Victory for access to medicines as Bayer loses lawsuit in India (GenericsWeb)… [read post]